Veterinary Medicines

Suprelorin 9.4 mg - Implant

Authorised
  • Deslorelin acetate
Download as PDF

Product identification

Medicine name:
Suprelorin 9.4 mg - Implant
Active substance:
  • Deslorelin acetate
Target species:
  • Dog
  • Ferret
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Deslorelin acetate
    11.76
    milligram(s)
    /
    1.00
    Implant
Pharmaceutical form:
  • Implant
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH01CA93
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Available in:
  • Austria
  • Belgium
  • Denmark
  • Estonia
  • Finland
  • France
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Sweden
  • United Kingdom (Northern Ireland)
Package description:
  • Packaging:Sealed foil pouch, Package_size:5 implants preloaded in implanters + 1 actuator
  • Packaging:Sealed foil pouch, Package_size:2 implants preloaded in implanters + 1 actuator

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 15/01/2026
Download
Bulgarian (PDF)
Published on: 15/01/2026
Download
Croatian (PDF)
Published on: 15/01/2026
Download
Czech (PDF)
Published on: 15/01/2026
Download
Danish (PDF)
Published on: 15/01/2026
Download
Dutch (PDF)
Published on: 15/01/2026
Download
Estonian (PDF)
Published on: 15/01/2026
Download
Finnish (PDF)
Published on: 15/01/2026
Download
French (PDF)
Published on: 15/01/2026
Download
German (PDF)
Published on: 15/01/2026
Download
Greek (PDF)
Published on: 15/01/2026
Download
Hungarian (PDF)
Published on: 15/01/2026
Download
Icelandic (PDF)
Published on: 15/01/2026
Download
Italian (PDF)
Published on: 15/01/2026
Download
Latvian (PDF)
Published on: 15/01/2026
Download
Lithuanian (PDF)
Published on: 15/01/2026
Download
Maltese (PDF)
Published on: 15/01/2026
Download
Norwegian (PDF)
Published on: 15/01/2026
Download
Polish (PDF)
Published on: 15/01/2026
Download
Portuguese (PDF)
Published on: 15/01/2026
Download
Romanian (PDF)
Published on: 15/01/2026
Download
Slovak (PDF)
Published on: 15/01/2026
Download
Slovenian (PDF)
Published on: 15/01/2026
Download
Spanish (PDF)
Published on: 15/01/2026
Download
Swedish (PDF)
Published on: 15/01/2026
Download

ema-puar-v109-suprelorin-initial-en.pdf

English (PDF)
Published on: 28/06/2024
Download

ema-puar-suprelorin-v-109-var-ii-0032-g-en.pdf

English (PDF)
Published on: 16/03/2023
Download

ema-puar-suprelorin-v-109-var-ii-0007-en.pdf

English (PDF)
Published on: 16/03/2023
Download